BREONICS Trademark

Trademark Overview


On Friday, March 3, 2023, a trademark application was filed for BREONICS with the United States Patent and Trademark Office. The USPTO has given the BREONICS trademark a serial number of 97822596. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2024. This trademark is owned by Breonics, Inc.. The BREONICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biomedical research services; Biotechnology research; Medical and scientific research in the field of bioengineering technologies and medical products for organ transplantation and tissue replacement; Medical and scientific research in the field of perfusion technologies for organ and tissue preservation; Medical research; Providing information about medical research in the field of bioengineering technologies and medical products for organ transplantation and tissue replacement; Providing information about medical research in the field of perfusion technologies for organ and tissue preservation; Research and development in the field of bioengineering technologies and medical products for organ transplantation and tissue replacement; Research and development in the field of perfusion technologies for organ and tissue preservation; Research and development in the pharmaceutical and biotechnology fields
breonics

General Information


Serial Number97822596
Word MarkBREONICS
Filing DateFriday, March 3, 2023
Status700 - REGISTERED
Status DateTuesday, March 26, 2024
Registration Number7338456
Registration DateTuesday, March 26, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Goods and ServicesBiomedical research services; Biotechnology research; Medical and scientific research in the field of bioengineering technologies and medical products for organ transplantation and tissue replacement; Medical and scientific research in the field of perfusion technologies for organ and tissue preservation; Medical research; Providing information about medical research in the field of bioengineering technologies and medical products for organ transplantation and tissue replacement; Providing information about medical research in the field of perfusion technologies for organ and tissue preservation; Research and development in the field of bioengineering technologies and medical products for organ transplantation and tissue replacement; Research and development in the field of perfusion technologies for organ and tissue preservation; Research and development in the pharmaceutical and biotechnology fields

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 23, 2023
Primary Code042
First Use Anywhere DateWednesday, May 8, 1996
First Use In Commerce DateThursday, June 13, 1996

Trademark Owner History


Party NameBreonics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlbany, NY 12205

Party NameBreonics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlbany, NY 12205

Party NameBreonics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlbany, NY 12205

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 1, 2023ASSIGNED TO EXAMINER
Thursday, March 23, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 7, 2023NEW APPLICATION ENTERED